HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States.
Healthequity stock last closed at $80.20, down 5.11% from the previous day, and has decreased 1.22% in one year. It has overperformed other stocks in the Health Information Services industry by 0.69 percentage points. Healthequity stock is currently +23.37% from its 52-week low of $65.01, and -30.62% from its 52-week high of $115.59.
At the moment, there are 86.5M shares of HQY outstanding. The market capitalization of HQY is $6.94B. In the past 24 hours, 1.06M HQY shares were traded.
How to Buy Healthequity Stock
Wondering how to invest in Healthequity stock? Here's how.
Choose where to buy Healthequity stock: You need to decide on an online brokerage, but don't worry - we've researched dozens of online brokerages and apps to help you decide where to buy Healthequity stock.
Create a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
Put funds into your brokerage account: Choose your method of payment and add your info.
Analyze Healthequity stock: The Healthequity ticker symbol is HQY. Is Healthequity stock a good investment? Should you buy shares of HQY? How do HQY's underlying business fundamentals look? Do top analysts think Healthequity is a good buy? Why has HQY's stock price moved recently? (Hint: Our stock market research tools can help you figure out if HQY is a good stock to buy).
Execute your HQY trade: Decide if you will purchase HQY shares at the current market price or use a limit order to purchase HQY stock at a particular price.
Keep an eye on your HQY investment: Create a watchlist to get the latest news on your new investment in Healthequity stock.
Step 1: Choose where to buy Healthequity stock
You need a brokerage account to access the NASDAQ market and buy HQY stock.
A brokerage account is an investment account that allows you to buy and sell a number of investments, including stocks, bonds, mutual funds, and ETFs.
Our recommended brokerage: eToro
Based on our analysis, eToro is the best stock brokerage. eToro gives you:
You can invest in stocks with zero commissions: Invest without commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
Access to global markets: From Tech to Financial Services, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
Social investing: eToro has a community of more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of other investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by creating an account with eToro now. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create a brokerage account
Now that you've picked the right brokerage, you'll need to fill out some personal info so you can invest in HQY stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Analyze Healthequity stock
Once you have figured out the best place to buy Healthequity stock, it's absolutely critical to research their stock prior to investing, so you truly comprehend the risk and upside.
Healthequity stock data
HQY Price
$80.20
1w %
-3.79%
1y %
-1.22%
5y %
73.07%
P/E
72.25x
P/B
3.28x
P/S
5.81x
PEG
1.27x
Revenue
$1.20B
Earnings
$96.70M
Fore. Rev. Growth
10.41%
Fore. Earn. Growth
56.91%
Market Cap
$6.94B
Next Earnings
Jun 2, 2025
Next Dividend
N/A
Healthequity Overview
WallStreetZen was created to help everyday investors perform better fundamental analysis in less time.
You can see all of the due diligence checks on HQY's stock page.
Is HQY stock overvalued?
You can use many financial metrics, analyses, models, and charts to gauge HQY's fair value.
Using relative valuations methods:
HQY could be overvalued based on its P/E ratio of 72.25x, relative to Health Information Services industry P/E ratio of 10.54x
HQY could be undervalued based on its P/B ratio of 3.28x, relative to Health Information Services industry P/B ratio of 3.29x
HQY could be overvalued based on its PEG ratio of 1.27x
HQY's operating cash flow of $339.86M allows it to safely service it's debt of $1.11B.
There are more short-term assets than short-term liabilities on the HQY balance sheet.
HQY profit margin has gone up from 5.6% to 8.1% in the past year.
Total HQY debt is lower than 5 years ago, relative to shareholder equity.
Negative Financial Indicators:
HQY has a relatively high debt to equity ratio of 0.63.
HQY earnings of $176.67M is not enough to cover its interest payments.
There are more long-term liabilities than short-term assets on the HQY balance sheet.
Is HQY stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 10 sell side analysts who research HQY, the consensus analyst rating on HQY is a Strong Buy
Please note that analyst forecasts are not recommendations, nor are they investment advice.
Most Recent HQY Analyst Upgrades/Downgrades
Constantine Davides, a bottom 2% analyst from JMP Securities maintains HQY with a buy rating and raises their HQY price target from $105.00 to $107.00, on Dec 10, 2024.
Sean Dodge, a top 19% analyst from RBC Capital maintains HQY with a buy rating and raises their HQY price target from $100.00 to $105.00, on Dec 10, 2024.
Steven Valiquette, a bottom 10% analyst from Mizuho initiates coverage on HQY with a buy rating and announces their HQY price target of $126.00, on Dec 4, 2024.
David Larsen, a bottom 11% analyst from BTIG maintains HQY with a strong buy rating and raises their HQY price target from $110.00 to $130.00, on Nov 14, 2024.
Allen Lutz, a top 27% analyst from Bank of America maintains HQY with a strong buy rating and raises their HQY price target from $100.00 to $120.00, on Nov 13, 2024.
Last year, HQY earnings were $96.70M. Over the past five year, HQY's earnings have increased by 13.47% per year. This was faster than the Health Information Services industry average of -3.92%.
Last year, HQY revenue was $1.20B. In the past 5 year, HQY's revenue has gone up by 17.66% per year. This was slower than the Health Information Services industry average of 22.41%.
No, Healthequity doesn't provide an income stream by paying out dividends.
What do other investors have to say about HQY?
One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
Step 5: Execute your HQY trade
There are two main types of orders:
Market order: A market order is an order to buy or sell a security at the best available price. Market orders are generally the easiest way to buy.
Limit order: A limit order lets you buy or sell a security at a specific price (or better). If you want to be certain you're buying or selling at a particular dollar amount, place a limit order.
Click the Open Trade button and eToro will execute your order.
If you need additional assistance investing in stocks on eToro, click the how to video below:
How much does it cost to buy one Healthequity share?
As of Apr 21, 2025, it costs $80.20 to buy one share of Healthequity stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.125 shares of HQY.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.